Abstract
The purpose of this study was to determine whether there is a correlation between large uterine fibroid diameter, uterine volume, number of vials of embolic agent used and risk of complications from uterine artery embolisation (UAE). This was a prospective study involving 121 patients undergoing UAE embolisation for symptomatic uterine fibroids at a single institution. Patients were grouped according to diameter of largest fibroid and uterine volume. Results were also stratified according to the number of vials of embolic agent used and rate of complications. No statistical difference in complication rate was demonstrated between the two groups according to diameter of the largest fibroid (large fibroids were classified as ≥10 cm; Fisher’s exact test P = 1.00), and no statistical difference in complication rate was demonstrated according to uterine volume (large uterine volume was defined as ≥750 cm3; Fisher’s exact test P = 0.70). 84 of the 121 patients had documentation of the number of vials used during the procedure. Patients were divided into two groups, with ≥4 used defined as a large number of embolic agent. There was no statistical difference between these two groups and no associated increased risk of developing complications. This study showed no increased incidence of complications in women with large-diameter fibroids or uterine volumes as defined. In addition, there was no evidence of increased complications according to quantity of embolic material used. Therefore, UAE should be offered to women with large fibroids and uterine volumes.
Similar content being viewed by others
References
Coleman P, Ayiku L, Nicholl J, Cross E (2004) National Institute for Clinical Excellence Interventional Procedures Programme: systematic review of the efficacy and safety of uterine artery embolisation in the treatment of fibroids. NICE Guidelines. http://www.nice.org.uk/nicemedia/live/11025/30602/30602.pdf
Ravina JH, Herbreteau D, Ciraru-Vigneron N, Bouret JM, Houdart E, Aymard A et al (1995) Arterial embolisation to treat uterine myomata. Lancet 346:671–672
Pelage JP, Dref OL, Soyer P et al (2000) Fibroid-related menorrhagia: treatment with superselective embolisation for symptomatic of the uterine arteries and midterm follow-up. Radiology 215:428–431
Worthington-Kirsch RL, Berkowiz RP, Hutchins FL (1998) Uterine artery embolisation for the management of leiomyomas: quality-of-life assessment and clinical response. Radiology 208:625–629
Goodwin SC, Vedantham S, McLucas B, Forno AE, Perrella R (1997) Preliminary experience with uterine artery embolisation for uterine fibroids. J Vasc Interv Radiol 8:517–526
Vashisht A, Studd J, Carey A et al (1999) Fatal septicaemia after fibroid embolisation. Lancet 354:307–308
Volkers NA, Hehenkamp WJ, Birnie E et al (2006) Uterine artery embolisation in the treatment of symptomatic uterine fibroid tumours (EMMY trial): periprocedural results and complications. J Vasc Interv Radiol 17:471–480
Spies JB, Ascher SA, Roth AR, Kim J, Levy EB, Gomez-Jorge J (2001) Uterine artery embolisation for leiomyomata. Obstet Gynaecol 98:29–34
Katsumori T, Nakajima K, Mihara T (2003) Is a large fibroid a high risk factor for uterine artery embolisation? AJR Am J Roentgenol 181:1309–1314
Firouznia K, Ghanaati H, Sanaati M, Jalali A (2008) Uterine artery embolization in 101 cases of uterine fibroids: do size, location and number of fibroids affect therapeutic success and complications? Cardiovasc Intervent Radiol 31:521–526
The British Society of Intervention Radiology (2009) UK Uterine Artery Embolisation for Fibroids Registry 2003–2008. Available at: http://www.bsir.org/content/BSIRPage.aspx?pageid=98. Accessed August 2008
Peddada SD, Laughlin SK, Miner K, Guyon JP (2008) Growth of uterine leiomyomata among pre-menopausal black and white women. Proc Natl Acad Sci USA 105:19887–19892
Prollius A, de Vries C, Logenberg E, du Plessis A, Nel M, Wessels PH (2004) Uterine artery embolisation for symptomatic fibroids: the effect of the large uterus on outcome. Br J Obstet Gynaecol 111:239–242
Bratby MJ, Belli A-M (2008) Radiological treatment of symptomatic uterine fibroids. Best Pract Res Clin Obstet Gynaecol 22:717–734
Goodwin SC, Bonilla SM, Sacks D, Reed RA, Spies JB et al (2003) Reporting standards for uterine artery embolisation for the treatment of uterine leiomyomata. J Vacs Interv Radiol 14:S467–476
Walker WJ, Watson GM (2002) Uterine artery embolisation for the treatment of symptomatic fibroids in 114 women: reduction in size of fibroids and women’s views of the success of the treatment. Br J Obstet Gynaecol 109:129–135
Goodwin SC, McLucas B, Lee M et al (1999) Uterine artery embolisation for the treatment of uterine leiomyoma midterm results. J Vasc Interv Radiol 10:1159–1165
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parthipun, A.A., Taylor, J., Manyonda, I. et al. Does Size Really Matter? Analysis of the Effect of Large Fibroids and Uterine Volumes on Complication Rates of Uterine Artery Embolisation. Cardiovasc Intervent Radiol 33, 955–959 (2010). https://doi.org/10.1007/s00270-010-9842-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-010-9842-x